Answers are grounded in this paper and cite their sources.
Case report reveals diagnostic challenges with ulcerative symptoms in Hodgkin lymphoma, suggesting EBV may be a treatment target.
Ulceration as cutaneous presentation of Hodgkin lymphoma (HL) is rare and needs to be differentiated from other dermatological or systemic conditions that present with chronic non-healing ulcers. Although the overall prognosis of Hodgkin lymphoma (HL) is generally favorable, we report a case of relapse presenting with erythematous plaques and ulcerated nodules. Histopathological and immunohistochemical analyses confirmed the diagnosis, revealing Reed-Sternberg cells positive for cluster of differentiation 30 (CD30) and Epstein-Barr virus latent membrane protein (EBV-LMP). Circulating EBV-DNA (deoxyribonucleic acid) may serve as a biomarker to monitor response to therapy in such patients, and eventually, EBV might become a target for therapeutic intervention also in HL.
No takes yet. Share an insight, caveat, or question.
Swati Prasanna (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: